Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

WHO recommends two Ebola vaccine candidates for trials as Bundibugyo outbreak spreads in DRC and Uganda with no approved treatment yet.

Unlike the more common Zaire strain, there are no approved medical interventions for deadly Bundibugyo

KINSHASA, May 31 — Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the...

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi

L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…

Four nurses discharged from DR Congo hospital after recovering from virus

Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...

While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...

The Serum Institute of India will produce trial doses of Oxford's experimental Ebola vaccine, supported by $8.6 million in CEPI funding to combat Bundibugyo ebolavirus outbreaks.

Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.

Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.